WASHINGTON--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ: FLDM) announced a new workflow that enables high throughput single-cell mRNA sequencing. This workflow, which was presented today at the Society for Neuroscience Conference, outlines significant advances in integrated fluidic circuit (IFC) design and chemistry to massively increase throughput and ease-of-use while simultaneously decreasing the cost of single-cell preparation. A full commercial version is expected to be available in the first half of 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
